Here's Everything You Need To Know About Parkinson's Disease, Including The Warning Signs And Who's Most At Risk
Former NFL player Brett Favre announced this week that he's been recently diagnosed with the condition. Here's what you should know, according to experts.
What Is Parkinson’s Disease?
Brett Favre announced his diagnosis on Tuesday. Here’s what we know about the disease and its relationship to head injuries.
What Is Parkinson's Disease? Here Are The Warning Signs And Who's Most At Risk.
Former NFL player Brett Favre announced this week he's been recently diagnosed with the condition. Here's what to know.
What to know about Parkinson's disease after Brett Favre's announcement
More than a decade after retiring from football, Brett Favre says he has Parkinson’s disease. Favre told a congressional hearing Tuesday that he had been recently diagnosed. There are nearly 90,000 new Parkinson’s cases each year in the U.S., according to the Parkinson's Foundation.
Following Brett Favre's Parkinson's diagnosis, here are other athletes, actors and singers who have faced the disease
Several prominent figures from all walks of life — including actors, singers and athletes — have been diagnosed with the disease over the years. Here are a few of those individuals and their stories.
Brett Favre's Parkinson's diagnosis reignites questions about football's link to brain disease
Research suggests that concussions from football can raise the risk of Parkinson’s and other neurodegenerative diseases.
Brett Favre says he has Parkinson's disease: What are the symptoms?
The legendary NFL quarterback, 54, told a congressional committee he has been diagnosed with the neurodegenerative condition while testifying about his alleged misuse of public funds.
How a Colorado Parkinson’s group uses climbing to help stave off effects of the disease
For 12 years, Paul Stroud’s done everything he can to combat the effects of Parkinson’s disease. He had a pair of stimulators ...
AbbVie's Parkinson's Disease drug meets main goal in late-stage trial
AbbVie said on Thursday its drug met the main goal in a late-stage trial in patients with early Parkinson's disease.
News Medical8h
Purine metabolism disruptions highlighted as crucial in Parkinson’s disease development
Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and debilitating effects on motor function.
FierceBiotech18h
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial
AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...
Medical Moment: New blood test detects Parkinson’s disease
A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...
Pitching for Parkinson’s in Grand Chute provides insight and support to those living with disease
The Wisconsin Parkinson’s Association held its second annual Pitching for Parkinson’s event on Thursday in Grand Chute as ...
Annovis Bio: Progress With Buntanetap In Parkinson's Disease, But Cash Runway Concerns Loom
Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...
Waco football coach, doctor weigh in on player safety following Brett Farve’s Parkinson’s diagnosis
Waco football coach, doctor weigh in on player safety following Brett Farve’s Parkinson’s diagnosis WACO, Texas (KWTX) - ...